ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 23, 1998

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

April 22, 1994

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

AACR Completes List Of Symposia Chairpersons

April 22, 1988